ARRY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Equity to Asset ratio is calculated as shareholders tangible equity divided by its total asset. Array BioPharma Inc's total equity for the quarter that ended in Dec. 2016 was $52.1 Mil. Array BioPharma Inc's total assets for the quarter that ended in Dec. 2016 was $272.2 Mil. Therefore, Array BioPharma Inc's Equity to Asset Ratio for the quarter that ended in Dec. 2016 was 0.19.
During the past 13 years, the highest Equity to Asset Ratio of Array BioPharma Inc was 0.93. The lowest was -1.55. And the median was 0.22.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing shareholders tangible equity divided by its total asset.
Array BioPharma Inc's Equity to Asset Ratio for the fiscal year that ended in Jun. 2016 is calculated as
Array BioPharma Inc's Equity to Asset Ratio for the quarter that ended in Dec. 2016 is calculated as
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher Return on Equity because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Array BioPharma Inc Annual Data
Array BioPharma Inc Quarterly Data